2026年8月21日 5:00 ET 发布 · 更新于 3 个月前 · 1 个来源
When AI designs a drug, who gets the credit?
MIT Technology Review
·
原始报道
When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
原文